AzTrials
AzTrials

Bronchopulmonary DysplasiaVPOCHNCT06512935

Ventilator Pressure and Optimization of Compliance and Hemodynamics

A study testing Increase in the PEEP followed by decrease in the PEEP and Decrease in the PEEP followed by increase in the PEEP in people with Bronchopulmonary Dysplasia and Pulmonary Hypertension Due to Lung Diseases and Hypoxia, run by University of Alabama at Birmingham at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

In preterm infants < 34 weeks' gestation at birth receiving respiratory support with invasive positive pressure ventilation, the positive end-expiratory pressure (PEEP) of best compliance will increase the cardiac output and improve oxygenation. Read more about this study

Who is it for?
Ages 7 to 30 days
What is being tested?
Increase in the PEEP followed by decrease in the PEEP and Decrease in the PEEP followed by increase in the PEEP
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteUnited States
Study dates
1 Oct 2026to 30 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 30 days
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Preterm infants with recovering respiratory distress syndrome (RDS) who were born at a gestational age < 34 weeks and are receiving respiratory support via conventional mechanical ventilation or on HFJV.
  • Post-natal age > 7 days and less than 1 month (outside golden week protocol)
  • Gestational age ≥ 21 weeks and ≤ 34 week
  • Infants with written informed consent obtained from legal guardian

Who cannot join

  • Blood culture-positive sepsis
  • Congenital anomalies affecting respiration
  • Cyanotic or ductal-dependent congenital heart disease
  • Newborns who are considered too unstable for study enrolment per neonatology attending
  • Newborns on pressors or steroids for maintaining cardiac output
  • Non-invasive ventilation or newborn with significant BPD (bronchopulmonary dysplasia) with pulmonary hypertension (HTN)
  • Open skin wounds or abrasions on the chest wall.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Kulsajan S Bhatia, MD contact

9172149882

ksbhatia@uabmc.edu

Colm P Travers, MD contact

cptravers@uabmc.edu

United States1 site, 1 recruiting
  • Univerisity of Alabama

    Birmingham, Alabama, 35233

    Recruiting

Other trials in United States

About this study

Official title: Ventilator Pressure and Optimization of Compliance and Hemodynamics: VPOCH Trial

In preterm infants < 34 weeks' gestation at birth receiving respiratory support with invasive positive pressure ventilation, the positive end-expiratory pressure (PEEP) of best compliance will increase the cardiac output and improve oxygenation. This study may emphasize using point-of-care echocardiography along with electrical impedance tomography (EIT) to optimize ventilator settings in preterm infants.

Infants will be randomized to a 4-hour crossover period of increasing and decreasing PEEP in random order from baseline to determine compliance, oxygenation, and cardiac hemodynamics at each step using echocardiography (ECHO) and EIT measurements. There will be a 15-minute washout period after changes prior to data collection.

Read the detailed description

In preterm infants < 34 weeks' gestation at birth receiving respiratory support with invasive positive pressure ventilation, the positive end-expiratory pressure (PEEP) of best compliance will increase the cardiac output and improve oxygenation. This study may emphasize using point-of-care echocardiography along with EIT to optimize ventilator settings in preterm infants.

Neonatal ventilation is a critical intervention to support breathing for newborns with respiratory distress syndrome (RDS), underdeveloped lungs, and evolving bronchopulmonary dysplasia (BPD). Positive airway pressure helps maintain patency of the airways and improves ventilation and oxygenation by maintaining the functional residual capacity (FRC) and keeping the alveoli patent. Peak inspiratory pressure (PIP) and positive end-expiratory pressure (PEEP) are terms commonly used in mechanical ventilation to describe the pressures applied to the respiratory system during the different phases of the breathing cycle. These parameters are essential in managing and optimizing ventilation for infants with respiratory failure.

This study will include preterm infants with recovering RDS born at age < 34 weeks of gestational age on respiratory support via conventional mechanical ventilation or on high-frequency jet ventilation (HFJV). Infants will be randomized to the order of testing, increasing the PEEP (+1 cmH2O and +2 cmH2O) or decreasing the PEEP (+1 cmH2O and +2 cmH2O) with baseline measurements and Echo done at original PEEP and each subsequent PEEP.

Following informed consent, randomization will be performed using sequentially numbered sealed opaque envelopes. The randomization envelope will be signed before it is opened just before starting the study on each infant to indicate the first intervention for the infant.

This will be a single-center, randomized crossover study. The randomization envelope will be signed before it is opened just before starting the study on each infant to indicate the first intervention for the infant.

Randomization will occur after a baseline assessment of cardiac hemodynamics and respiratory status at the current set PEEP level. Infants will be randomized to the order of changes in PEEP levels during mechanical ventilation - increase followed by decrease versus decrease followed by increase. Randomization will use opaque sealed envelopes of varying block sizes from 2-4 with a 1:1:1:1 allocation ratio.

Infants will be randomized to a 4-hour crossover period of increasing and decreasing PEEP in random order from baseline and there will be a 15-minute washout period after changes before data collection.

All infants enrolled in the study will have routine monitoring, uniform target saturation ranges of 91-95% with alarm limits set at 88-95%, and standard care for the duration of the study. Pulse oximetry recordings will be downloaded using ixTrend (iexcellence, Wildau, Germany) software to a secure computer system for later data analysis.

Infants will continue standard treatment as recommended by the treating physician and will act as their own controls.

Primary secondary outcomes are described below. Electrical impedance tomography data will be collected in the Syntec machine and safely secured in the university computer system. Pulse oximetry recordings will be downloaded using ixTrend software to a secure computer system for later data analysis.

ECHO results will be stored in the unit ECHO machine and results will be reported by certified cardiologists blinded to the data collected to improve the study design's internal and external validity.

Being tested
Increase in the PEEP followed by decrease in the PEEP, Decrease in the PEEP followed by increase in the PEEP
Keywords
Respiratory distress syndrome, ventilation mechanics in newborn, cardiac hemodynamics newborn
Medical subject headings
Bronchopulmonary Dysplasia, Hypoxia, Respiratory Distress Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Increase in the PEEP followed by decrease in the PEEPOther

    Changes in the ventilator PEEP and its effect on lung and cardiac hemodynamics

  • Decrease in the PEEP followed by increase in the PEEPOther

    Changes in the ventilator PEEP and its effect on lung and cardiac hemodynamics

Study groups in NCT06512935
Study groupRoleWhat they receive
cardiac hemodynamics and respiratory status assessment with increasing PEEPExperimentalInfants will be randomized to the order of changes in PEEP levels during mechanical ventilation - increase followed by decrease in PEEP. Baseline parameters looking into cardiac hemodynamics as well as compliance and respiratory mechanics will be assessed using EIT
Receives: Other: Increase in the PEEP followed by decrease in the PEEP
cardiac hemodynamics and respiratory status assessment with decreasing PEEPActive comparatorInfants will be randomized to the order of changes in PEEP levels during mechanical ventilation - decrease followed by increase in PEEP. Baseline parameters looking into cardiac hemodynamics as well as compliance and respiratory mechanics will be assessed using EIT
Receives: Other: Decrease in the PEEP followed by increase in the PEEP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in cardiac index with increase/decrease in PEEP as measured by ECHO and EIT

    Measured: During a 4 hour cross-over period on either intervention

  2. PEEP of best compliance and best oxygenation as per EIT measurements

    Measured: During a 4 hour cross-over period on either intervention

Secondary outcomes (7)
  1. Tidal volume variation

    Measured: During a 4 hour cross-over period on either intervention

  2. Oxygen saturation index

    Measured: During a 4 hour cross-over period on either intervention

  3. End-expiratory lung impedance (EELI), End-inspiratory lung impedance (EILI)

    Measured: During a 4 hour cross-over period on either intervention

  4. Transcutaneous carbon dioxide (TcCO2) values in response to varying PEEP levels

    Measured: During a 4 hour cross-over period on either intervention

  5. Respiratory Severity Score (RSS)

    RSS: mean airway pressure (MAP) x fraction of inspired oxygen (FiO2)

    Measured: During a 4 hour cross-over period on either intervention

  6. oxygen saturation (SpO2) values

    Measured: During a 4 hour cross-over period on either intervention

  7. % tidal distribution

    Measured: During a 4 hour cross-over period on either intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jul 2024
  2. Study start1 Oct 2026
  3. Primary completion1 May 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Single centre, randomized crossover study. This study will include preterm infants with recovering RDS born at age \< 34 weeks of gestational age on respiratory support via conventional mechanical ventilation or on HFJV. Infants will be randomized to the order of testing, increasing the PEEP (+1 cmH2O and +2 cmH2O) or decreasing the PEEP (+1 cmH2O and +2 cmH2O) with baseline measurements and Echo done at original PEEP and at each subsequent PEEP.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06512935
Sponsor's protocol ID
IRB-300013132
Other IDs
UAB
Acronym
VPOCH
Status last verified
Oct 2026
First submitted
5 Jul 2024
Last updated
26 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Increase in the PEEP followed by decrease in the PEEP and Decrease in the PEEP followed by increase in the PEEP in people with Bronchopulmonary Dysplasia and Pulmonary Hypertension Due to Lung Diseases and Hypoxia, run by University of Alabama at Birmingham at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kulsajan S Bhatia, MD (9172149882, ksbhatia@uabmc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in cardiac index with increase/decrease in PEEP as measured by ECHO and EIT (time frame: During a 4 hour cross-over period on either intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in